Selecting functional siRNA target Sites of hUBE2W based on H1-U6 dual promoter RNAi plasmid

Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology

Volumn 24, Issue 11, 2008, Pages 1975-1980

  Zhang, Yingying ^a   Li, Chao ^a   Yang, Zhixin ^a   Xu, Long ^a   Zhu, Hengqi ^a   Zhou, Xiaowei ^a   Huang, Peitang ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

HUBE2W; RNA interference (RNAi); Ubiquitin conjugating enzyme

Indexed keywords

MESSENGER RNA; SMALL INTERFERING RNA; SMALL NUCLEAR RNA; U6 SMALL NUCLEAR RNA; UBIQUITIN CONJUGATING ENZYME;

ARTICLE; BIOSYNTHESIS; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PLASMID; PROMOTER REGION; RNA INTERFERENCE;

BASE SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; PLASMIDS; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA, SMALL NUCLEAR; UBIQUITIN-CONJUGATING ENZYMES;

EID: 70349316819     PISSN: 10003061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Prendergast JA, Ptak C, Steussy CN, et al. Identification of a positive regulator of the cell cycle ubiquitinconjugating enzyme Cdc34 (Ubc3). Mol Cell Biol, 1996, 2(16): 677-684.
2. Okamoto Y, Ozaki T, Miyazaki K, et al. UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme. Cancer Res, 2003, 63: 4167-4173.
3. Zhao GY, Sonoda E, Barber LJ, et al. A critical role for the ubiquitin-conjugating enzyme Ubc13 in initiating homologous recombination. Mol Cell, 2007, 25: 663-675.
4. Zhang YY, Zhu HQ, Zhao LX, et al. Generation of mouse UBE2W antibody and analysis of UBE2W expression in mouse tissues. Chin J Biotech, 2008, 24(4): 547-552.
5. Wang RX, Xu JC, Saram-ki O, et al. PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer. Cancer Res, 2004, 64: 1589-1594.
6. Porkka K, Saram-ki O, Tanner M, et al. Amplification and overexpression of elongin C gene discovered in prostate cancer by cDNA microarrays. Lab Invest, 2002, 82(5): 629-637.
7. Chen C, Sun X, Guo P, et al. Ubiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancer. Oncogene, 2007, 26: 2386-2394.
8. Christensen DE, Brzovic PS, Klevit RE. E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages. Nat Struct Mol Biol, 2007, 14(10): 941-948.
9. Wu WW, Koike A, Takeshita T, et al. The ubiquitin E3 ligase activity of BRCA1 and its biological functions. Cell Div, 2008, 3: 1.
10. Birmingham A, Anderson E, Sullivan K, et al. A protocol for designing siRNAs with high functionality and specificity. Nature Protocols, 2007, 2(9): 2068-2078.
11. Harborth J, Elbashir SM, Bechert K, et al. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J Cell Sci, 2001, 114:4557-4565.
12. Hammolld SM, Caudy AA, Hannon G. Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet, 2001, 2: 110-119.
13. Kaykas A, Moon RT. A plasmid-based system for expressing small interfering RNA libraries in mammalian cells. BMC Cell Biol, 2004, 5:16.
14. Tran N, Cairns MJ, Dawes IW, et al. Expressing functional siRNAs in mammalian cells using convergent transcription. BMC Biotechno, 2003, 3: 21.
15. Jian R, Cheng XX, Peng T, et al. RNA interference mediated by U6 and H1 dual promoter vector. China Biotechnology, 2004, 11(24): 26-31
16. Jian R, Cheng XX, Jiang X, et al. A cDNA-based random RNA interference library for functional genetic screens in embryonic stem cells. Stem Cells, 2007, 25(8): 1904-1912.